199 related articles for article (PubMed ID: 23534861)
1. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis.
Kingsberg SA; Krychman ML
J Sex Med; 2013 Jun; 10(6):1567-74. PubMed ID: 23534861
[TBL] [Abstract][Full Text] [Related]
2. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.
Safary M; Hakimi S; Mobaraki-Asl N; Amiri P; Tvassoli H; Delazar A
Curr Drug Deliv; 2020; 17(9):815-822. PubMed ID: 32640956
[TBL] [Abstract][Full Text] [Related]
4. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
Lynch C
J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
[TBL] [Abstract][Full Text] [Related]
5. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
6. Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy.
Sulaica E; Han T; Wang W; Bhat R; Trivedi MV; Niravath P
Breast Cancer Res Treat; 2016 Jun; 157(2):203-210. PubMed ID: 27178335
[TBL] [Abstract][Full Text] [Related]
7. Vaginal estrogens for the treatment of dyspareunia.
Krychman ML
J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
[TBL] [Abstract][Full Text] [Related]
8. A Dermatologist's Approach to Genitourinary Syndrome of Menopause.
Hum M; Dytoc M
J Cutan Med Surg; 2017; 21(5):418-424. PubMed ID: 28453946
[TBL] [Abstract][Full Text] [Related]
9. Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance.
Pinkerton JV; Kaunitz AM; Manson JE
Menopause; 2017 Dec; 24(12):1329-1332. PubMed ID: 29040220
[No Abstract] [Full Text] [Related]
10. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Genitourinary Syndrome of Menopause.
Hodges AL; Holland AC; Dehn B; Pace DT
Nurs Womens Health; 2018 Oct; 22(5):423-430. PubMed ID: 30170002
[TBL] [Abstract][Full Text] [Related]
12. Aloe Vera; A new treatment for atrophic vaginitis, A randomized double-blinded controlled trial.
Poordast T; Ghaedian L; Ghaedian L; Najib FS; Alipour S; Hosseinzadeh M; Vardanjani HM; Salehi A; Hosseinimehr SJ
J Ethnopharmacol; 2021 Apr; 270():113760. PubMed ID: 33383112
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
Archer DF
Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
[TBL] [Abstract][Full Text] [Related]
14. Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets.
Mainini G; Scaffa C; Rotondi M; Messalli EM; Quirino L; Ragucci A
Clin Exp Obstet Gynecol; 2005; 32(2):111-3. PubMed ID: 16108394
[TBL] [Abstract][Full Text] [Related]
15. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management.
Gandhi J; Chen A; Dagur G; Suh Y; Smith N; Cali B; Khan SA
Am J Obstet Gynecol; 2016 Dec; 215(6):704-711. PubMed ID: 27472999
[TBL] [Abstract][Full Text] [Related]
16. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of hyaluronic acid and estrogen on atrophic vaginitis in menopausal women: A systematic review.
Najjarzadeh M; Mohammad Alizadeh Charandabi S; Mohammadi M; Mirghafourvand M
Post Reprod Health; 2019 Jun; 25(2):100-108. PubMed ID: 30798700
[No Abstract] [Full Text] [Related]
18. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
[TBL] [Abstract][Full Text] [Related]
19. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
20. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
Tan O; Bradshaw K; Carr BR
Menopause; 2012 Jan; 19(1):109-17. PubMed ID: 22011753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
